SST-102

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSST-102
Drug Alias NameSST-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionWingless type MMTV integration site family protein inhibitorsCatenin beta 1 degraders
TargetsCatenin beta 1Wingless type MMTV integration site family protein
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStemSynergy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemSynergy Therapeutics Inc
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A